Pharma

Gland Pharma Ltd

GLAND · NSE · INE068V01023
——consolidatedstandalone
Sentiment81 · Extreme Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E45.5
P/B5.0
EPS₹68.47
Div Yield0.7%
ROE10.5%
ROCE13.5%
ROE10.5%
1Y Return+81.38%
Avg. Volume0.7M

Price Chart

3,1162,7362,3561,9771,59743.8L87.6LOct 2025Nov 2025Dec 2025Feb 2026Mar 2026Apr 2026May 2026Jul 2026Aug 2026

About

Gland Pharma Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price—
52W High / Low—
Stock P/E45.5
Price to Book5.0
EPS (TTM)₹68.47
Dividend Yield0.7%
ROE10.5%
1Y Return+81.38%
Day Change—

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20
Sales₹6,725 Cr₹6,431 Cr₹5,616 Cr
Expenses₹4,974 Cr₹4,801 Cr₹4,348 Cr
Operating Profit₹1,751 Cr₹1,630 Cr₹1,269 Cr
OPM %26.0%25.0%23.0%
Other Income₹296 Cr₹292 Cr₹214 Cr
Depreciation₹434 Cr₹424 Cr₹378 Cr
Interest₹26 Cr₹33 Cr₹42 Cr
Profit Before Tax₹1,587 Cr₹1,465 Cr₹1,063 Cr
Tax₹458 Cr₹438 Cr₹364 Cr
Net Profit₹1,129 Cr₹1,027 Cr₹699 Cr
EPS (₹)68.562.442.4
Dividend Payout %—32%42%
Financial history locked

Register free to see 5 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹1,800 Cr₹1,743 Cr₹1,695 Cr₹1,487 Cr
Expenses₹1,311 Cr₹1,230 Cr₹1,260 Cr₹1,173 Cr
Operating Profit₹489 Cr₹513 Cr₹435 Cr₹314 Cr
OPM %27.0%29.0%26.0%21.0%
Depreciation₹111 Cr₹109 Cr₹108 Cr₹106 Cr
Interest₹4 Cr₹10 Cr₹4 Cr₹8 Cr
Net Profit₹317 Cr₹367 Cr₹261 Cr₹184 Cr
EPS (₹)19.222.315.911.2
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20
Liabilities
Equity Capital₹16 Cr₹16 Cr₹16 Cr
Reserves₹10,341 Cr₹9,134 Cr₹8,707 Cr
Borrowings₹284 Cr₹314 Cr₹372 Cr
Other Liabilities₹1,808 Cr₹1,709 Cr₹1,516 Cr
Total Liabilities₹12,449 Cr₹11,173 Cr₹10,611 Cr
Assets
Fixed Assets₹4,492 Cr₹4,147 Cr₹3,947 Cr
Investments₹0 Cr₹0 Cr₹0 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹7,614 Cr₹6,875 Cr₹6,426 Cr
Total Assets₹12,449 Cr₹11,173 Cr₹10,611 Cr
Balance sheet history locked

Register free to see 5 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹1,031 Cr₹188 Cr₹-417 Cr₹803 Cr
FY25₹915 Cr₹1,718 Cr₹-433 Cr₹2,199 Cr
FY24₹997 Cr₹-1,749 Cr₹-799 Cr₹-1,552 Cr
FY23
FY22
FY21
FY20
Cash flow history locked

Register free to see 5 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd₹353 Cr75.3+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-10-07Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE Filing2026-08-12Gland Pharma Ltd (NSE:GLAND) (Q1 2027) Earnings Call Highlights: Record 20% Revenue Growth and ...GuruFocus.com2026-08-07Earnings To Watch: Gland Pharma Ltd (NSE:GLAND) Q1 2027 -- GF Value Sees 5% DownsideGuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.